The Use of Intravenous Human Immunoglobulin in Treatment of Severe Pemphigus Foliaceus in a Dog
2006; Wiley; Volume: 20; Issue: 6 Linguagem: Inglês
10.1111/j.1939-1676.2006.tb00770.x
ISSN1939-1676
AutoresLouisa J. Rahilly, John H. Keating, Therese E. O'Toole,
Tópico(s)Coagulation, Bradykinin, Polyphosphates, and Angioedema
ResumoJournal of Veterinary Internal MedicineVolume 20, Issue 6 p. 1483-1486 Open Access The Use of Intravenous Human Immunoglobulin in Treatment of Severe Pemphigus Foliaceus in a Dog Louisa J. Rahilly, Louisa J. Rahilly Matthew J. Ryan Veterinary Hospital of the University of Pennsylvania, Cummings School of Veterinary Medicine at Tufts University Matthew J. Ryan Veterinary Hospital of the University of Pennsylvania, 3900 Delancey St, Philadelphia, PA 19104; e-mail: [email protected].Search for more papers by this authorJohn H. Keating, John H. Keating Department of Biomedical Sciences, Cummings School of Veterinary Medicine at Tufts University.Search for more papers by this authorTherese E. O'Toole, Therese E. O'Toole Department of Biomedical Sciences, Cummings School of Veterinary Medicine at Tufts University.Search for more papers by this author Louisa J. Rahilly, Louisa J. Rahilly Matthew J. Ryan Veterinary Hospital of the University of Pennsylvania, Cummings School of Veterinary Medicine at Tufts University Matthew J. Ryan Veterinary Hospital of the University of Pennsylvania, 3900 Delancey St, Philadelphia, PA 19104; e-mail: [email protected].Search for more papers by this authorJohn H. Keating, John H. Keating Department of Biomedical Sciences, Cummings School of Veterinary Medicine at Tufts University.Search for more papers by this authorTherese E. O'Toole, Therese E. O'Toole Department of Biomedical Sciences, Cummings School of Veterinary Medicine at Tufts University.Search for more papers by this author First published: 05 February 2008 https://doi.org/10.1111/j.1939-1676.2006.tb00770.xCitations: 22 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Lewis DT. Life-threatening dermatoses in dogs. Compend Contin Educ Pract Vet 1998; 20: 271–283. Web of Science®Google Scholar 2 Marsella R. Canine pemphigus complex: Pathogenesis and clinical presentation. Compend Contin Educ Pract Vet 2000; 22: 568–572. Web of Science®Google Scholar 3 Wurm S., Mattise AW, Dunstan RW. Comparative pathology of pemphigus in dogs and humans. Clin Dermatol 1994; 12: 515–524. 10.1016/0738-081X(94)90218-6 CASPubMedWeb of Science®Google Scholar 4 Scott DW, Manning TO, Smith CA, et al. Observations on the immunopathology and therapy of canine pemphigus and pemphigoid. J Am Vet Med Assoc 1982; 180: 48–52. CASPubMedWeb of Science®Google Scholar 5 Ihrke PJ, Stannard AA, Ardans AA, et al. Pemphigus foliaceus in dogs: A review of 37 cases. J Am Vet Med Assoc 1985; 186: 59–66. CASPubMedWeb of Science®Google Scholar 6 White SD, Rosychuk RA, Reinke SI, et al. Use of tetracycline and niacinamide for treatment of autoimmune skin disease in 31 dogs. J Am Vet Med Assoc 1992; 200: 1497–1500. CASPubMedWeb of Science®Google Scholar 7 Katzatchkine MD, Kaveri SV. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 2001; 345: 747–755. 10.1056/NEJMra993360 PubMedWeb of Science®Google Scholar 8 Simon HU, Späth PJ. IVIG—Mechanisms of action. Allergy 2003; 58: 543–552. 10.1034/j.1398-9995.2003.00239.x CASPubMedWeb of Science®Google Scholar 9 Knezevic-Maramica I., Kruskall MS. Intravenous immune globulins: An update for clinicians. Transfusion 2003; 43: 1460–1480. 10.1046/j.1537-2995.2003.00519.x CASPubMedWeb of Science®Google Scholar 10 Scott-Moncrieff JCR, Reagan WJ. Human intravenous immunoglobulin therapy. Sem Vet Med Surg (Sm Animal) 1997; 12: 178–185. 10.1016/S1096-2867(97)80031-X CASPubMedWeb of Science®Google Scholar 11 Jolles S., Hughes J., Whittaker S. Dermatoligical uses of high-dose intravenous immunoglobulin. Arch Dermatol 1998; 134: 80–86. 10.1001/archderm.134.1.80 CASPubMedWeb of Science®Google Scholar 12 Dahl MV, Bridges AG. Intravenous immune globulin: Fighting antibodies with antibodies. J Am Acad Dermatol 2001; 45: 775–783. 10.1067/mjd.2001.119085 CASPubMedWeb of Science®Google Scholar 13 Sami N., Bhol KC, Ahmed AR. Influence of IVIg therapy on autoantibody titers to desmoglein 1 in patients with pemphigus foliaceus. Clin Immunol 2002; 105: 192–198. 10.1006/clim.2002.5278 CASPubMedWeb of Science®Google Scholar 14 Ahmed AR, Sami N. Intravenous immunoglobulin therapy for patients with pemphigus foliaceus unresponsive to conventional therapy. J Am Acad Dermatol 2002; 46: 42–49. 10.1067/mjd.2002.116338 PubMedWeb of Science®Google Scholar 15 Werner LL, Brown KA, Halliwell REW. Diagnosis of autoimmune skin disease in the dog: Correlation between histopathologic, direct immunofluorescent and clinical findings. Vet Immunol and Immunopath 1983; 5: 47–64. 10.1016/0165-2427(83)90031-4 PubMedWeb of Science®Google Scholar 16 Parker WM, Yager JA. Trichophyton dermatophytosis—A disease easily confused with pemphigus erythmatosus. Can Vet J 1997; 38: 502–505. CASPubMedWeb of Science®Google Scholar 17 Fairley RA. Case report: The histological lesions of Trichophyton mentagrophytes var erinacei infection in dogs. Vet Derm 2001; 12: 119–122. 10.1046/j.1365-3164.2001.00235.x CASPubMedWeb of Science®Google Scholar 18 Scott-Moncrieff JCR, Reagan WJ, Glickman LT, et al. Treatment of nonregenerative anemia with human gamma globulin in dogs. J Am Vet Med Assoc 1995; 206: 1895–1900. CASPubMedWeb of Science®Google Scholar 19 Scott-Mondcrieff JCR, Reagan WJ, et al. Intravenous administration of human immune globulin in dogs with immune-mediated hemolytic anemia. J Am Vet Med Assoc 1997; 210: 1623–1627. PubMedWeb of Science®Google Scholar 20 Kellerman DL, Bruyette DS. Intravenous human immunoglobulin for the treatment of immune-mediated hemolytic anemia in 13 dogs. J Vet Int Med 1997; 11: 327–332. 10.1111/j.1939-1676.1997.tb00475.x CASPubMedWeb of Science®Google Scholar 21 Byrne KP, Giger U. Uses of human immunoglobulin for the treatment of severe erythema multiforme in a cat. J Am Vet Med Assoc 2002; 220: 197–201. 10.2460/javma.2002.220.197 PubMedWeb of Science®Google Scholar Citing Literature Volume20, Issue6November 2006Pages 1483-1486 ReferencesRelatedInformation
Referência(s)